Lijun Xu

机构：Harbin Medical University · ORCID：0000-0001-9515-6128

发表论文 175 篇 · 总被引 4875 次 · h-index 37

代表论文

• BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance (2024 · Molecular Cancer · 被引 28)
• Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by modulating SRSF1-mediated alternative splicing (2024 · Oncogene · 被引 11)
• LncRNA CRCMSL interferes in phospholipid unsaturation to suppress colorectal cancer progression via reducing membrane fluidity (2025 · Journal of Advanced Research · 被引 10)
• Oxyberberine Inhibits Hepatic Gluconeogenesis via AMPK ‐Mediated Suppression of FoxO1 and CRTC2 Signaling Axes (2024 · Phytotherapy Research · 被引 9)
• Triglyceride-glucose index: a novel prognostic marker for sepsis-associated encephalopathy severity and outcomes (2025 · Frontiers in Neurology · 被引 7)
• Magnetic Shield Design and Simulation Optimization of Metallic Magnetic Calorimeter in Ultra-Low Temperature Working State (2024 · Journal of Low Temperature Physics · 被引 4)